1Sacks GF,Pfeffer MA,Moye IA.The effect of pravastation on coronary events after myocardial infarction in patients with average cholesterol levels[J].N Engl J Med,1996,335(14):1001.
2The long-term intervention with pravastatin in Ischaemic Disease (LIPID) study Group.Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J].N Engl J Med,1998,339(19):1349.
3Maseri A.Inflammation,atherosclerosis,and ischemic events-exploring the hidden side of the moon[J].N Engl J Med,1997,336(14):1014.
4Rus H,Niculescu FI.Inflammation,aspirin,and the risk of cardiovascular disease[J].N Engl J Med,1997,337 (6):423.
8Strandberg TE,Vanhanen H,Tikkanen MJ.Associations between change in C-reactive protein and serum lipids during statin treatment[J].Ann Med,2000,32(8):579.
2Waters DD,Azar RR.Should intensive cholesterol lowering play a role in the management of acute coronary syndrome[J].Am J cardiol,2000,86(8B):355-435.
3Hashimoto M,Akita H.Cerivastatin,a hydroxymethylglutaryl coenzyme a reductase inhibitor,improves endothelial function in elderly diabetic patients within 3 days[J].Circulation,2002,105(1):E30-E31.
4Rauch U,Osende JI,Chesebro JH,et al.Statins and cardiovascular disease:the multiple effects of lipid-lowering therapy by statins[J].Atherosclerosis,2000,153(1):181-189.
